Skip to content

Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration

Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02450825
Enrollment
77
Registered
2015-05-21
Start date
2015-07-31
Completion date
2017-02-28
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Atelectasis, Dyspnea, Hypoxemia, Pneumonia, Pulmonary Embolism

Brief summary

This study is designed to compare three ultrasound-based aeration scores that were previously validated in specific populations, and to assess their correlation with computed tomographic measurement of pulmonary aeration in a population with different pathologies. Hypothesis: The Loss of Aeration Score will be more accurate than a simplified version and another widely used score, the Lung Ultrasound Score.

Detailed description

Assessment of lung aeration may have a great impact in the management of mechanical ventilation and follow-up of diverse lung pathologies. Computed tomographic scan is the gold standard method of lung aeration measurement but is rarely used because it requires transport of critically ill patients end exposes them to radiations. For these reasons, lung ultrasound would be an attractive alternative. Variants of different ultrasound-based aeration scores have been validated in different specific populations, but there is no comparison study that defines the more accurate score that should be used in a population with different pathologies. Methods: Patients undergoing a computed tomographic scan for dyspnea or hypoxemia will have a standardized lung ultrasound examination on Day 1. For mechanically ventilated patients only, a lung ultrasound examination will be repeated on Day 2 to 4. End expiratory lung volume will also be measured in mechanically ventilated patients on Day 1 and Day 2 to 4. Lung ultrasound images will be interpreted blindly. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.

Interventions

PROCEDURELung ultrasound examination on Day 1 and Day 2 to 4

A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 and repeated on Day 2 to 4. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.

PROCEDURELung ultrasound examination on Day 1

A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 only. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.

DEVICEGE Vivid Ultrasound system

The GE Vivid ultrasound system will be used for all lung ultrasound examinations performed in this study.

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalized or visiting the emergency room * Will undergo a computed tomographic scan for dyspnea or hypoxemia

Exclusion criteria

* Poor echogenicity (morbid obesity, multiple thoracic dressings) * Contraindications to superior limbs or torso mobilization

Design outcomes

Primary

MeasureTime frame
Correlation of ultrasound-based aeration scores with computed tomographic measurement of pulmonary aeration.Day 1

Secondary

MeasureTime frameDescription
Correlation of ultrasound-based aeration scores and expiratory lung volume variation.Day 2 to Day 4In mechanically ventilated patients, correlation of ultrasound-based aeration scores and expiratory lung volume variation between Day 1 and Day 2 to 4 will be assessed.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026